Home
Choose language  
Drugs Sideaffects Drugs Sideaffects
Drugs Index : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
 
Welcome Sideaffects Information of drug
 
 
Latest News About Abilify
FDA OKs Abilify for secondary use against bipolar disorder - CNNMoney.com
...More
European Marketing Authorization For Abilify - For Severe Manic ... - Medical News Today
...More
Aripiprazole Receives Expanded Paediatric Indications for Bipolar ... - DG News

DG News - 9 May 2008
TOKYO and PRINCETON, NJ -- May 9, 2008 -- Aripiprazole (Abilify) is now indicated for maintenance treatment of manic and mixed episodes associated with ...
...More
Antipsychotics in Kids May Add Weight - WebMD

WebMD - 7 May 2008
They were prescribed one of three medications: Zyprexa, Risperdal, or Abilify. "Virtually 100% of the kids exposed to the medications had some degree of ...
...More
Should kids get these drugs? Plan likely to increase scrutiny of ... - TheNewsTribune.com

TheNewsTribune.com, WA - 11 May 2008
They™re sold under the names Zyprexa, Geodon, Risperdal, Abilify, Seroquel, Clozaril and Invega. The drugs belong to a relatively new class of ...
...More
Earnings Preview: Bristol-Myers Squibb's 1st-quarter report - Forbes

Forbes, NY - 22 Apr 2008
In February, the company's bipolar disorder drug Abilify received expanded approval for use in adolescents, opening up another market for the treatment. ...
...More
Bristol-Myers's Net Falls 4.2% As Generic Competition Looms - Wall Street Journal
...More
Aripiprazole may be effective for alcohol addiction - Reuters

Reuters - 17 Apr 2008
Aripiprazole, sold in the US under the trade name Abilify, is an atypical antipsychotic that increases the sedative effects of alcohol, while decreasing its ...
...More
Author : Bristol-Myers Squibb Company - Earthtimes (press release)
...More
Bristol-Myers Squibb Co. Q1 2008 Earnings Call Transcript - Seeking Alpha

Seeking Alpha, NY - 24 Apr 2008
Highlights include 24% worldwide growth of a ABILIFY and a 39% increase in global sales of PLAVIX, as well as continued strong results from HIV and ...
...More